The aldo-keto reductase superfamily catalyzes the reduction of a broad range of aldehydes and ketones to their corresponding alcohols. Here we report the cloning of the mouse aldehyde reductase cDNA and its embryonic pattern of expression. From stages E7.5 to E13.5 the gene encoding for this enzyme is expressed at high levels in several tissues, including the neural ectoderm, gut endoderm, somites, branchial arches, otic vesicles, limb buds, and tail bud. In adult mice aldehyde reductase was expressed in all tissues examined. q
Results
Aldehyde reductase, a member of the aldo-keto reductase superfamily, catalyzes the NADP(H)-dependent reduction of a broad range of aldehydes to their corresponding alcohols (Jez et al., 1997a) . Although the physiological role of this enzyme remains to be established, putative biological functions have been proposed. These include the metabolism of neurotransmitter aldehydes produced by monoamine oxidase (Turner et al., 1974) , detoxi®cation of reactive aldehyde intermediates (Takahashi et al., 1993) , and osmoregulation (Garcia-Perez and Burg, 1991) . Aldehyde reductase cDNAs have been previously isolated from human (Bohren et al., 1989) , rat (Takahashi et al., 1993) and pig (Flynn et al., 1995) . We report here the cloning and embryonic expression of mouse aldehyde reductase.
A full-length (1320 bp) cDNA was isolated from an E8.5 mouse cDNA library, using a 257 bp fragment obtained by a differential display screen (Fig. 1) . Comparison of the predicted coding region to other aldehyde reductase cDNAs showed 97% (rat), 93% (human), and 91% (pig) identity, suggesting a high degree of evolutionary conservation. We have named this cDNA mouse aldehyde reductase or AKR1A4 in accordance with the proposed nomenclature for the aldo-keto reductase superfamily (Jez et al., 1997b) .
Expression of AKR1A4 was assessed by whole-mount in situ hybridization from E7.5 to E13.5 (Fig. 2) . At E7.5 AKR1A4 was weakly but broadly expressed (Fig. 2B) . At E8.5, high levels of expression were seen in neural ectoderm ( Fig. 2C±F ) and gut endoderm (Fig. 2E ). Lower levels of message were detected in mesenchyme at the level of the open neural tube (Fig. 2C,D) and somites ( Fig. 2F) . At E9.0 AKR1A4 transcripts were present along the entire neural axis and gut endoderm (Fig. 2G±J) . High levels of expression were also observed in the ectoderm overlying the ®rst branchial arch (Fig. 2H ), otic placode (Fig. 2G,H) , and tail bud mesenchyme (Fig. 2J ). At E9.5 and E10.5 AKR1A4 was strongly expressed in limb buds (Figs. 2K and 3E), frontonasal mass, branchial arches, otic vesicle and tail bud (Fig.  2K±M) . Expression in the neural tube diminished at E9.5 ( Fig. 2L ) and was no longer detectable by E10.5. At E11.5 high levels of AKR1A4 transcripts were localized in the ectoderm and underlying mesoderm of the limb buds (Figs. 2N,O and 3A,F) as well as in the tail (Fig. 2N) , with weaker expression in surface and adjacent mesenchyme of the trunk (Fig. 2N±P) . From E12.5 to E13.5, expression in the facial region declined (Fig. 2N ,Q,S), while transcripts in the developing limbs became more restricted to the distal ectoderm and interdigital mesenchyme (Figs. 2Q±T and 3B,C,G,H). By E14.5 expression in the forelimbs (00)00293-8 www.elsevier.com/locate/modo was absent (data not shown) and was restricted to the edges of the presumptive digits in the hindlimbs (Fig. 3D) . Expression at E13.5 and E14.5 in lungs revealed a low background of AKR1A4 throughout the mesenchyme, with markedly elevated expression in the segmental (Fig. 3I ,J) and terminal bronchi (Fig. 3K,L) .
Northern blot analysis revealed the presence of AKR1A4 transcripts in all adult tissues examined (Fig. 4) . However, levels varied markedly, with expression highest in kidney and lowest in muscle and spleen. This expression pattern is similar to that observed for the cognate rat homologue (Takahashi et al., 1993) .
Taken together, developmental expression of AKR1A4 appears pronounced in some structures undergoing high rates of growth. Given this, it is tempting to speculate a critical role for this enzyme during embryogenesis, perhaps to neutralize potentially toxic aldehydes produced as a consequence of the high metabolic activity in these tissues.
Experimental procedures

Differential display PCR (DD-PCR)
Differential display was performed as described (Liang and Pardee, 1992) . cDNA fragments were cloned into pGEM w -T (Promega) and sequenced with T7 polymerase (Amersham Pharmacia Biotech).
Isolation of full length AKR1A4 cDNA
A mouse E8.5 cDNA library was screened with the 257 bp DD-PCR fragment. One of three positives clones isolated was found to contain the entire predicted coding region (1320 bp). Sequence analysis was performed with Wisconsin Package Version 10.0, Genetics Computer Group (GCG), Madison, WI.
In situ hybridization
The full-length AKR1A4 cDNA was cloned into KS 1 and used to generate full-length riboprobes. Whole-mount in situ hybridization was performed on E7.5±E13.5 mouse embryos and E13.5 and E14.5 mouse lungs according to Henrique et al. (1995) . Following hybridization, embryos were embedded in Paraplast, sectioned at 7 mm and counterstained with eosin B. Abbreviations: ba, branchial arch; da, dorsal aorta; fg, foregut;¯b, forelimb bud; fnm, frontonasal mass; h, heart; hg, hindgut; hlb, hind limb bud; ic, intra-embryonic coelomic cavity; mg, midgut; ne, neuroepithelium; np, neural plate; nt, neural tube; oc, optic cup; op, otic placode; pc, pericardio-peritoneal canal; pnp, posterior neuropore; s, somite; se, surface ectoderm; tb, tailbud.
Northern blot analysis
Tissues were collected from adult CD1 mice. RNA, isolated by Trizol (Gibco-BRL), was resolved on a denaturing gel and transferred to Genescreen 1 (DuPont NEN). Blots were hybridized according the manufacturer with full-length AKR1A4 cDNA labeled by random priming. An 18 s rRNA probe was used as a loading control. 
